Real-world outcomes of venetoclax and rituximab for chronic lymphocytic leukemia/small lymphocytic lymphoma: A retrospective analysis of nine Japanese cases

Masuho Saburi; Takumi Nishikawa; Yasuhiko Miyazaki; Kazuhiro Kohno; Masanori Sakata; Kazuki Okuhiro; Toshiyuki Nakayama; Eiichi Ohtsuka; Masao Ogata

doi:10.3960/jslrt.24014

Short Communication

Real-world outcomes of venetoclax and rituximab for chronic lymphocytic leukemia/small lymphocytic lymphoma: A retrospective analysis of nine Japanese cases

Masuho Saburi , Takumi Nishikawa, Yasuhiko Miyazaki, Kazuhiro Kohno, Masanori Sakata, Kazuki Okuhiro, Toshiyuki Nakayama, Eiichi Ohtsuka, Masao Ogata

Author information

Masuho Saburi Corresponding author
Department of Hematology, Oita Prefectural Hospital, Oita, Japan,
Takumi Nishikawa
Department of Hematology, Oita Prefectural Hospital, Oita, Japan,
Yasuhiko Miyazaki
Department of Hematology, Oita Prefectural Hospital, Oita, Japan,
Kazuhiro Kohno
Department of Hematology, Oita Kouseiren Tsurumi Hospital, Oita, Japan,
Masanori Sakata
Department of Hematology, Oita University Hospital, Oita, Japan
Kazuki Okuhiro
Department of Hematology, Oita University Hospital, Oita, Japan
Toshiyuki Nakayama
Department of Hematology, Oita Kouseiren Tsurumi Hospital, Oita, Japan,
Eiichi Ohtsuka
Department of Hematology, Oita Prefectural Hospital, Oita, Japan,
Masao Ogata
Department of Hematology, Oita University Hospital, Oita, Japan

Keywords: chronic lymphocytic leukemia, small lymphocytic lymphoma, venetoclax, rituximab, Japanese

JOURNAL OPEN ACCESS

2024 Volume 64 Issue 2 Pages 152-155

DOI https://doi.org/10.3960/jslrt.24014

Details

Corresponding author

Register with J-STAGE for free!